Chemoinformaics analysis of 10-Bromostrictosidine
| Molecular Weight | 609.47 | nRot | 7 |
| Heavy Atom Molecular Weight | 576.206 | nRig | 29 |
| Exact Molecular Weight | 608.137 | nRing | 5 |
| Solubility: LogS | -2.31 | nHRing | 4 |
| Solubility: LogP | 1.092 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 39 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 33 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 10 |
| nHA | 10 | APOL | 79.5622 |
| nHD | 6 | BPOL | 43.4378 |
| QED | 0.198 |
| Synth | 4.951 |
| Natural Product Likeliness | 2.047 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.169 |
| HIA | 0.915 |
| CACO-2 | -5.687 |
| MDCK | 0.0000268 |
| BBB | 0.661 |
| PPB | 0.668885 |
| VDSS | 0.764 |
| FU | 0.55352 |
| CYP1A2-inh | 0.023 |
| CYP1A2-sub | 0.136 |
| CYP2c19-inh | 0.026 |
| CYP2c19-sub | 0.302 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.248 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.333 |
| CYP3a4-inh | 0.275 |
| CYP3a4-sub | 0.465 |
| CL | 0.993 |
| T12 | 0.227 |
| hERG | 0.705 |
| Ames | 0.397 |
| ROA | 0.922 |
| SkinSen | 0.033 |
| Carcinogencity | 0.942 |
| EI | 0.005 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.013 |
| Antiviral | Yes |
| Prediction | 0.867854 |